The Reporting and Methodological Recommendations for Observational Studies Estimating the Effects of Deprescribing Medications (REMROSE-D) ISPE-Endorsed Guidance [0.03%]
药物减药效应的观察性研究的报告和方法学推荐（REMROSE-D）国际制药工程师协会认可指南
Kaleen N Hayes,Joshua D Niznik,Danijela Gnjidic et al.
Kaleen N Hayes et al.
Purpose: Pharmacoepidemiologic studies on deprescribing are challenging to implement, yet little guidance exists on methods to avoid bias and minimum reporting for replicability and appraisal. We developed consensus recom...
Safety of BNT162b2 mRNA COVID-19 Vaccine Batches: A Nationwide Cohort Study [0.03%]
BNT162b2mRNACOVID-19疫苗批次的安全性：一项全国队列研究
Max Schmeling,Vibeke Manniche,Peter Riis Hansen
Max Schmeling
Performance of the Self-Controlled Case Series With Active Comparators for Drug Safety Signal Detection Using the French Administrative Healthcare Database (SNDS) [0.03%]
基于法国行政健康数据库（SNDS）的自我控制病例系列与活性对照药物不良反应信号检测效果研究
Astrid Coste,Angel Y S Wong,François Haguinet et al.
Astrid Coste et al.
Background: The self controlled case series (SCCS) is one of the most promising methods for drug safety signal detection using real world data (RWD), and incorporating active comparators could potentially improve its perf...
Strengthening Pharmacoepidemiology in a Changing Research Environment: The European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) [0.03%]
在变化的研究环境中加强药物流行病学研究：欧洲药物流行病学和药品警戒中心网络(ENCePP)
Xavier Kurz,Catherine Cohet,Susana Perez-Gutthann et al.
Xavier Kurz et al.
Key changes in the pharmacoepidemiological research environment had a significant influence on the activities of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (ENCePP) over the last decade. These changes inc...
Suitability of Japanese Medical Databases for Studies on Infant Outcomes After Maternal Drug Exposure: An Evaluation Based on Core Data Elements [0.03%]
基于核心数据元素评估日本医疗数据库用于研究药物暴露对婴幼儿结局的适用性
Shiro Hatakeyama,Takamasa Sakai,Masami Tsuchiya et al.
Shiro Hatakeyama et al.
Purpose: Pharmacotherapy during pregnancy should be approached with caution due to the potential risk of adverse effects, including birth defects, in the fetus. Appropriate post-marketing surveillance and perinatal pharma...
Uncovering Medication Errors Leading to Hospital Admissions in the Emergency Department: An External, Prospective Validation of Clinical Decision Rules [0.03%]
在急诊科导致住院的用药错误的外部、前瞻性验证临床决策规则的研究
Nadjia Amini,Sabrina De Winter,Sanne Nijs et al.
Nadjia Amini et al.
Purpose: Drug-related admissions (DRAs) remain highly prevalent and are linked with increased morbidity and mortality. Rapid and accurate identification is key to both their acute management and secondary prevention. To t...
Performance of the Self-Controlled Case Series With Active Comparators for Drug Safety Signal Detection Using Merative MarketScan Research Databases [0.03%]
基于Merative MarketScan研究数据库的活性对照自我控制病例系列法检测药物信号的效果研究
Astrid Coste,Angel Y S Wong,Francois Haguinet et al.
Astrid Coste et al.
Background: Despite testing of epidemiological methods in US Claims databases for signal detection, such data sources have not become a routine capability. The Self Controlled Case Series (SCCS) is one of the most promisi...
Validation of the US Food and Drug Administration's COVID-19 Disease Severity Categorization for Use in Real-World Data [0.03%]
美国食品药品监督管理局新冠肺炎疾病严重程度分类的验证以在真实世界数据中的应用
Silvia Perez-Vilar,Wei Hua,Andrew Kwist et al.
Silvia Perez-Vilar et al.
Background: The US Food and Drug Administration proposed a five-level disease severity categorization for baseline COVID-19 (asymptomatic, mild, moderate, severe, critical). ...
Detection of Adverse Medicine Events by Pharmacists in Residential Aged Care Facilities: Secondary Analysis of Data From ReMInDAR Trial [0.03%]
药物不良事件的检测：基于ReMInDAR试验的二次分析研究
Abebe Basazn Mekuria,Renly Lim,Andre Q Andrade et al.
Abebe Basazn Mekuria et al.
Background: Pharmacists often identify symptoms during medication reviews that may or may not be adverse medicine events (AMEs), but these have not yet been quantified. This study aimed to quantify the extent of these sym...
The Effect of Use of Tricyclic Antidepressants or Serotonin-Norepinephrine Reuptake Inhibitors Versus Selective Serotonin Reuptake Inhibitors on the Risk of Urinary Tract Infection Among People With Multiple Sclerosis: A Nested Case-Control Study [0.03%]
三环类抗抑郁药或.serotonin-norepinephrine.再摄取抑制剂与选择性血清素再摄取抑制剂相比对于多发性硬化病患者尿路感染风险的影响：一项病例对照研究
Melissa W Y Leung,Ewoudt M W van de Garde,Bernard M J Uitdehaag et al.
Melissa W Y Leung et al.
Purpose: To study the effect of tricyclic antidepressant (TCA)/selective serotonin-norepinephrine reuptake inhibitor (SNRI) versus selective serotonin reuptake inhibitor (SSRI) on the risk of urinary tract infection (UTI)...
Comparative Study
Pharmacoepidemiology and drug safety. 2025 Nov;34(11):e70260. DOI:10.1002/pds.70260 2025